DPM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sumitomo Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 11 EUR 5.36% Market Closed

Market Cap: €4.4B

S	Sumitomo Pharma Co Ltd F:DPM	JP
	Biontech SE NASDAQ:BNTX	DE
	Greenlane Holdings Inc NASDAQ:GNLN	US
I	IHI Corp OTC:IHICF	JP
M	Makus Inc KOSDAQ:093520	KR
E	Eaton Corporation PLC XMUN:3EC	IE
C	Clarus Corp F:BDO	US

Profitability Summary

Sumitomo Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

62% > 55%

Healthy Operating Margin

21%

Negative 3Y Average Operating Margin

-22%

Operating Margin is Increasing

-39% > 21%

Healthy Net Margin

24%

Negative 3Y Average Net Margin

-22%

Net Margin is Increasing

-35% > 24%

Exceptional Free Cash Flow Margin

15%

Negative 3Y Average Free Cash Flow Margin

-18%

Free Cash Flow Margin is Increasing

-53% > 15%

Exceptional ROE

39%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-4%

ROIC is Increasing

-17% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

62% > 55%

Healthy Operating Margin

21%

Negative 3Y Average Operating Margin

-22%

Operating Margin is Increasing

-39% > 21%